Advertisement
Screener

PALATIN TECHNOLOGIES, INC. (PTN) Payments to Acquire Investments

2.0 / 5 stars · 28/71 Roast Me

PALATIN TECHNOLOGIES, INC. Payments to Acquire Investments

PALATIN TECHNOLOGIES, INC. (PTN) reported Payments to Acquire Investments of $0 for the 12-month period ending 2018-06-30, per its 10-K filed 2018-09-13.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireInvestments · last filed 2018-09-13

  • PALATIN TECHNOLOGIES, INC. payments to acquire investments for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
  • PALATIN TECHNOLOGIES, INC. payments to acquire investments for the quarter ending 2013-09-30 was $6.24K, a 27.03% decline year-over-year.
  • PALATIN TECHNOLOGIES, INC. payments to acquire investments for the quarter ending 2013-06-30 was $0.00.
  • PALATIN TECHNOLOGIES, INC. payments to acquire investments for the quarter ending 2013-03-31 was $5.98M.
  • PALATIN TECHNOLOGIES, INC. payments to acquire investments for fiscal 2018 was $0.00.
  • PALATIN TECHNOLOGIES, INC. payments to acquire investments for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
  • PALATIN TECHNOLOGIES, INC. payments to acquire investments for fiscal 2016 was $1.39M.
  • PALATIN TECHNOLOGIES, INC. payments to acquire investments for fiscal 2015 was $0.00.
Period endPayments to Acquire Investments 3 monthPayments to Acquire Investments 6 monthPayments to Acquire Investments 9 monthPayments to Acquire Investments 12 monthPayments to Acquire Investments 12 month as first filed
2018-06-30$0.00
10-K · filed 2018-09-13
2017-06-30$0.00
10-K · filed 2018-09-13
2016-06-30$1.39M
10-K · filed 2018-09-13
2015-12-31$1.39M
10-Q · filed 2016-02-12
2015-06-30$0.00
10-K · filed 2017-09-25
2014-12-31$0.00
10-Q · filed 2016-02-12
2014-06-30$0.00
10-K · filed 2016-09-19
-$5.25M
10-K · filed 2014-09-12
2013-12-31$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14
$6.24K
10-Q · filed 2014-02-14
$6.24K
derived: sum of 3 quarters · filed 2015-09-18
$5.98M
derived: sum of 4 quarters · filed 2015-09-18
2013-09-30$6.24K
10-Q · filed 2013-11-13
$6.24K
derived: sum of 2 quarters · filed 2015-09-18
$5.98M
derived: sum of 3 quarters · filed 2015-09-18
$6.00M
derived: sum of 4 quarters · filed 2015-09-18
2013-06-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-18
$5.98M
derived: sum of 2 quarters · filed 2015-09-18
$5.99M
derived: sum of 3 quarters · filed 2015-09-18
$6.00M
10-K · filed 2015-09-18
2013-03-31$5.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12
$5.99M
derived: sum of 2 quarters · filed 2014-05-12
$6.00M
10-Q · filed 2014-05-12
2012-12-31$13.22K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14
$21.77K
10-Q · filed 2014-02-14
2012-09-30$8.55K
10-Q · filed 2013-11-13
2012-06-30$0.00
10-K · filed 2014-09-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lipocine Inc. (LPCN)United States$0.017B-1.79
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Rocket One Inc. (RKTO)United States$0.019B
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B